Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BBOX1 | O75936 | 5/20 | 0.47 |
| ▸ | TSHR | P16473 | 3/20 | 0.45 |
| ▸ | THRB | P10828 | 1/20 | 0.39 |
| ▸ | POLB | P06746 | 2/20 | 0.36 |
| ▸ | APEX1 | P27695 | 1/20 | 0.36 |
| ▸ | HTT | P42858 | 1/20 | 0.36 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.36 |
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
| ▸ | LMNA | P02545 | 1/20 | 0.32 |
| ▸ | GRK2 | P25098 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.32 |
| ▸ | CHRM5 | P08912 | 1/20 | 0.32 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.32 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16799116 | 0.96 | TSHR (0.47) | BBOX1TSHRTHRBPOLBAPEX1 | |
| SCHEMBL16798910 | 0.94 | TSHR (0.50) | BBOX1TSHRTHRBPOLBAPEX1 | |
| SCHEMBL18151499 | 0.94 | TSHR (0.50) | BBOX1TSHRTHRBPOLBAPEX1 | |
| SCHEMBL16799119 | 0.94 | TSHR (0.46) | BBOX1TSHRTHRBPOLBAPEX1 | |
| SCHEMBL1547906 | 0.94 | TSHR (0.50) | BBOX1TSHRTHRBPOLBAPEX1 | |
| SCHEMBL16799121 | 0.94 | TSHR (0.50) | BBOX1TSHRTHRBPOLBAPEX1 | |
| SCHEMBL18151862 | 0.94 | TSHR (0.46) | BBOX1TSHRTHRBPOLBAPEX1 | |
| SCHEMBL16799360 | 0.94 | TSHR (0.50) | BBOX1TSHRTHRBPOLBAPEX1 | |
| SCHEMBL16799567 | 0.94 | TSHR (0.46) | BBOX1TSHRTHRBPOLBAPEX1 | |
| SCHEMBL16799049 | 0.94 | TSHR (0.46) | BBOX1TSHRTHRBPOLBAPEX1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 61 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4165465-B1 | SYSTEMS AND METHODS FOR INDICATING THE TIME ELAPSED SINCE THE OCCURRENCE OF A TRIGGERING EVENT | JOHNSON & JOHNSON VISION CARE (US) | 2026-02-18 | — | — | EP | disclosed |
| US-12509583-B2 | Particle surface modification to increase compatibility and stability in hydrogels | JOHNSON & JOHNSON VISION CARE, INC. (US) | 2025-12-30 | — | — | US | disclosed |
| US-20250161025-A1 | COMPOSITIONS, DEVICES, AND METHODS FOR PREVENTING POSTERIOR CAPSULE OPACIFICATION (PCO) | OHIO STATE INNOVATION FOUNDATION | 2025-05-22 | — | — | US | disclosed |
| EP-4515302-A1 | LIGHT-FILTERING MATERIALS FOR BIOMATERIAL INTEGRATION AND METHODS THEREOF | Johnson & Johnson Vision Care, Inc. (US) | 2025-03-05 | — | — | EP | disclosed |
| EP-4515301-A1 | SHAPE ENGINEERING OF PARTICLES TO CREATE A NARROW SPECTRAL FILTER AGAINST A SPECIFIC PORTION OF THE LIGHT SPECTRUM | Johnson & Johnson Vision Care, Inc. (US) | 2025-03-05 | — | — | EP | disclosed |
| EP-4515307-A1 | THERMALLY STABLE NANOPARTICLES AND METHODS OF MAKING THEM | Johnson & Johnson Vision Care, Inc. (US) | 2025-03-05 | — | — | EP | disclosed |
| EP-4515304-A1 | PARTICLE SURFACE MODIFICATION TO INCREASE COMPATIBILITY AND STABILITY IN HYDROGELS | Johnson & Johnson Vision Care, Inc. (US) | 2025-03-05 | — | — | EP | disclosed |
| EP-4515303-A1 | USING PARTICLES FOR LIGHT FILTERING | Johnson & Johnson Vision Care, Inc. (US) | 2025-03-05 | — | — | EP | disclosed |
| CN-118055935-A | Anthraquinone-functionalized polymerization initiators and their use in the manufacture of ophthalmic lenses | 强生视力健公司 | 2024-05-17 | — | — | CN | disclosed |
| CN-113874780-B | Multifocal contact lenses exhibiting improved vision properties | 强生视力健公司 | 2024-05-14 | — | — | CN | disclosed |
| EP-3077476-B1 | NANOCRYSTALS COMPLEXED WITH FUNCTIONALIZABLE ENHANCED AFFINITY LIGANDS AND USE THEREOF | NEXDOT (FR) | 2020-02-12 | — | — | EP | disclosed |
| US-10465030-B2 | Nanoparticles complexed with functionalizable enhanced affinity ligands and use thereof | NEXDOT (FR) | 2019-11-05 | — | — | US | disclosed |
| US-20190161563-A1 | PROTEIN AGGREGATION INHIBITOR | OSAKA ORGANIC CHEMICAL INDUSTRY LTD. (JP) | 2019-05-30 | — | — | US | disclosed |
| US-20190002459-A1 | HYDROXYPHENYL PHENANTHROLINES AS POLYMERIZABLE BLOCKERS OF HIGH ENERGY LIGHT | JOHNSON & JOHNSON VISION CARE, INC. | 2019-01-03 | — | — | US | disclosed |
| US-20190002415-A1 | HYDROXYPHENYL NAPHTHOTRIAZOLES AS POLYMERIZABLE BLOCKERS OF HIGH ENERGY LIGHT | JOHNSON & JOHNSON VISION CARE, INC. | 2019-01-03 | — | — | US | disclosed |
| US-20180118859-A1 | PROTEIN AGGREGATION INHIBITOR | OSAKA ORGANIC CHEMICAL INDUSTRY LTD. (JP) | 2018-05-03 | — | — | US | disclosed |
| EP-3296314-A1 | PROTEIN AGGREGATION INHIBITOR | Osaka Organic Chemical Industry Ltd. (JP) | 2018-03-21 | — | — | EP | disclosed |
| US-20160304648-A1 | NANOPARTICLES COMPLEXED WITH FUNCTIONALIZABLE ENHANCED AFFINITY LIGANDS AND USE THEREOF | NEXDOT (FR) | 2016-10-20 | — | — | US | disclosed |
| EP-3077476-A1 | NANOPARTICLES COMPLEXED WITH FUNCTIONALIZABLE ENHANCED AFFINITY LIGANDS AND USE THEREOF | Nexdot (FR) | 2016-10-12 | — | — | EP | disclosed |
| WO-2015082656-A1 | NANOPARTICLES COMPLEXED WITH FUNCTIONALIZABLE ENHANCED AFFINITY LIGANDS AND USE THEREOF | NEXDOT (FR) | 2015-06-11 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12509583-B2 | Particle surface modification to increase compatibility and stability in hydrogels | MYH10, MYOC, UACA | BBOX1 2704/4885TSHR 910/4885THRB 3011/4885 |
| US-20190002459-A1 | HYDROXYPHENYL PHENANTHROLINES AS POLYMERIZABLE BLOCKERS OF HIGH ENERGY LIGHT | HRH2, HRH3, HRH1 | BBOX1 1000/4885TSHR 3007/4885THRB 2569/4885 |
| US-20190002415-A1 | HYDROXYPHENYL NAPHTHOTRIAZOLES AS POLYMERIZABLE BLOCKERS OF HIGH ENERGY LIGHT | HRH3, HMGB3, CRYAB | BBOX1 2143/4885TSHR 2809/4885THRB 3242/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.